This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive molecules. It serves as a key intermediate in the creation of potential drug candidates targeting various diseases, including cancer and neurological disorders. Its structure, featuring a trifluoromethyl group and a bromo substituent, makes it valuable for modifying the pharmacokinetic and pharmacodynamic properties of lead compounds. Additionally, it is employed in organic synthesis to explore novel chemical reactions and pathways, contributing to advancements in medicinal chemistry and drug discovery.